BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15356022)

  • 21. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
    Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, genetic, and immunohistochemical characterization of 70 Ukrainian adult cases with post-Chornobyl papillary thyroid carcinoma.
    Dinets A; Hulchiy M; Sofiadis A; Ghaderi M; Höög A; Larsson C; Zedenius J
    Eur J Endocrinol; 2012 Jun; 166(6):1049-60. PubMed ID: 22457234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V; Vieira de Castro I; Soares P; Máximo V; Silva P; Magalhães J; Abrosimov A; Guiu XM; Sobrinho-Simões M
    J Pathol; 2004 Feb; 202(2):247-51. PubMed ID: 14743508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation induced thyroid cancer: fundamental and applied aspects.
    Tronko M; Bogdanova T; Voskoboynyk L; Zurnadzhy L; Shpak V; Gulak L
    Exp Oncol; 2010 Sep; 32(3):200-4. PubMed ID: 21403618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma.
    Salvatore G; Giannini R; Faviana P; Caleo A; Migliaccio I; Fagin JA; Nikiforov YE; Troncone G; Palombini L; Basolo F; Santoro M
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5175-80. PubMed ID: 15472223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
    Rabes HM; Demidchik EP; Sidorow JD; Lengfelder E; Beimfohr C; Hoelzel D; Klugbauer S
    Clin Cancer Res; 2000 Mar; 6(3):1093-103. PubMed ID: 10741739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI; Moraes L; Bastos AU; Besson P; Alves MT; Delcelo R; Monte O; Longui C; Cury AN; Cerutti JM
    Thyroid; 2017 Feb; 27(2):182-188. PubMed ID: 27849443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics.
    Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE
    Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problem of prevalence of ret/PTC rearrangements in thyroid tumors.
    Saenko VA; Rogounovitch TI; Abrosimov AY; Takamura N; Lushnikov EF; Namba H; Yamashita S
    Thyroid; 2002 May; 12(5):435-6. PubMed ID: 12097207
    [No Abstract]   [Full Text] [Related]  

  • 30. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
    Hamatani K; Eguchi H; Ito R; Mukai M; Takahashi K; Taga M; Imai K; Cologne J; Soda M; Arihiro K; Fujihara M; Abe K; Hayashi T; Nakashima M; Sekine I; Yasui W; Hayashi Y; Nakachi K
    Cancer Res; 2008 Sep; 68(17):7176-82. PubMed ID: 18757433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
    Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
    Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L; Mannavola D; Cirello V; Vannucchi G; Muzza M; Vicentini L; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2004 Aug; 61(2):239-43. PubMed ID: 15272920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [BRAF gene mutation in thyroid cancer].
    Kopczyńska E; Junik R; Tyrakowski T
    Pol Merkur Lekarski; 2006 Feb; 20(116):210-3. PubMed ID: 16708643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of childhood papillary thyroid carcinomas after irradiation: high prevalence of RET rearrangement.
    Rabes HM; Klugbauer S
    Recent Results Cancer Res; 1998; 154():248-64. PubMed ID: 10027005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic alterations of differentiated thyroid carcinoma in iodine-rich and iodine-deficient countries.
    Vuong HG; Kondo T; Oishi N; Nakazawa T; Mochizuki K; Inoue T; Tahara I; Kasai K; Hirokawa M; Tran TM; Katoh R
    Cancer Med; 2016 Aug; 5(8):1883-9. PubMed ID: 27264674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
    Giordano TJ; Kuick R; Thomas DG; Misek DE; Vinco M; Sanders D; Zhu Z; Ciampi R; Roh M; Shedden K; Gauger P; Doherty G; Thompson NW; Hanash S; Koenig RJ; Nikiforov YE
    Oncogene; 2005 Oct; 24(44):6646-56. PubMed ID: 16007166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort.
    Bogdanova TI; Zurnadzhy LY; Nikiforov YE; Leeman-Neill RJ; Tronko MD; Chanock S; Mabuchi K; Likhtarov IA; Kovgan LM; Drozdovitch V; Little MP; Hatch M; Zablotska LB; Shpak VM; McConnell RJ; Brenner AV
    Br J Cancer; 2015 Dec; 113(11):1556-64. PubMed ID: 26625214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment.
    Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
    Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl.
    Mitsutake N; Fukushima T; Matsuse M; Rogounovitch T; Saenko V; Uchino S; Ito M; Suzuki K; Suzuki S; Yamashita S
    Sci Rep; 2015 Nov; 5():16976. PubMed ID: 26584635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid and simple detection method for the BRAF(T1796A) mutation in fine-needle aspirated thyroid carcinoma cells.
    Hayashida N; Namba H; Kumagai A; Hayashi T; Ohtsuru A; Ito M; Saenko VA; Maeda S; Kanematsu T; Yamashita S
    Thyroid; 2004 Nov; 14(11):910-5. PubMed ID: 15671769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.